(Q40305380)

19 September 2017

Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice (English)

1 reference

19 September 2017

0 references

1 reference

Timothy J Seabrook

1

1 reference

19 September 2017

Liying Jiang

series ordinal

2

1 reference

19 September 2017

Marcel Maier

series ordinal

3

1 reference

19 September 2017

Cynthia A Lemere

series ordinal

4

1 reference

19 September 2017

1 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

53

1 reference

19 September 2017

776-782

1 reference

19 September 2017

7

1 reference

Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein

19 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

Inflammation and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Generation of amyloid beta protein from its precursor is sequence specific

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Inhibitory effect of minocycline on amyloid beta fibril formation and human microglial activation.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

High-yield isolation of murine microglia by mild trypsinization.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Species-specific immune response to immunization with human versus rodent A beta peptide.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Microglia as neuroprotective, immunocompetent cells of the CNS.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20338

7 January 2021

Identifiers

DOI

10.1002/GLIA.20338

1 reference

19 September 2017

1 reference